Literature DB >> 17700377

Increasing chlamydia positivity in women screened in family planning clinics: do we know why?

David Fine1, Linda Dicker, Debra Mosure, Stuart Berman.   

Abstract

OBJECTIVE: Following a 9-year 60% decline, chlamydia positivity increased 46% from 1997 through 2004 among young sexually active women screened in Region X family planning clinics. The objective of this analysis was to systematically examine the influences of risk factors, changing laboratory test methods, and interclinic variability on chlamydia positivity during this period. STUDY
DESIGN: We analyzed data from 520,512 chlamydia tests from women aged 15 to 24 years screened in 125 family planning clinics. Multivariate logistic regression modeling was used to adjust the annual risk of chlamydia for the demographic, clinical, and sexual risk behavior characteristics associated with infection and for the increasing use of more sensitive laboratory test methods. A generalized linear mixed model was used to adjust for interclinic variability.
RESULTS: We found a significant 5% annual increase in the risk of chlamydia even after adjusting for risk factors including laboratory test characteristics (odds ratio 1.05, 95% confidence interval: 1.04, 1.06). Variability among the clinics where screening occurred did not account for the increase.
CONCLUSIONS: Based on a review of all available data, we concluded that there was a true increase in chlamydia positivity over the 8-year period.

Entities:  

Mesh:

Year:  2008        PMID: 17700377     DOI: 10.1097/OLQ.0b013e31813e0c26

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  15 in total

1.  Chlamydia positivity in women screened in family planning clinics: racial/ethnic differences and trends in the northwest U.S., 1997-2006.

Authors:  David Fine; Katherine K Thomas; Wendy Nakatsukasa-Ono; Jeanne Marrazzo
Journal:  Public Health Rep       Date:  2012 Jan-Feb       Impact factor: 2.792

2.  Chlamydia trachomatis infection among women reporting sexual activity with women screened in Family Planning Clinics in the Pacific Northwest, 1997 to 2005.

Authors:  Devika Singh; David N Fine; Jeanne M Marrazzo
Journal:  Am J Public Health       Date:  2010-08-19       Impact factor: 9.308

3.  Comparison of five commercial serological tests for the detection of anti-Chlamydia trachomatis antibodies.

Authors:  D Baud; L Regan; G Greub
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-28       Impact factor: 3.267

4.  Chlamydia positivity trends among women attending family planning clinics: United States, 2004-2008.

Authors:  Catherine Lindsey Satterwhite; LaZetta Grier; Rachel Patzer; Hillard Weinstock; Penelope P Howards; David Kleinbaum
Journal:  Sex Transm Dis       Date:  2011-11       Impact factor: 2.830

Review 5.  Chlamydia trachomatis today: treatment, detection, immunogenetics and the need for a greater global understanding of chlamydial disease pathogenesis.

Authors:  D Dean
Journal:  Drugs Today (Barc)       Date:  2009-11       Impact factor: 2.245

6.  A randomized trial of home versus clinic-based sexually transmitted disease screening among men.

Authors:  Mary M Reagan; Hanna Xu; Shirley L Shih; Gina M Secura; Jeffrey F Peipert
Journal:  Sex Transm Dis       Date:  2012-11       Impact factor: 2.830

7.  How do changes in the population tested for chlamydia over time affect observed trends in chlamydia positivity? Analysis of routinely collected data from young women tested for chlamydia in family planning clinics in the Pacific Northwest (USA), between 2003 and 2010.

Authors:  Sarah C Woodhall; Lizzi Torrone; David Fine; Sarah G Salomon; Wendy Nakatsukasa-Ono; Kate Soldan; Hillard Weinstock
Journal:  Sex Health       Date:  2015-11       Impact factor: 2.706

8.  Chlamydia screening in England: a qualitative study of the narrative behind the policy.

Authors:  Jessica Sheringham; Paula Baraitser; Ian Simms; Graham Hart; Rosalind Raine
Journal:  BMC Public Health       Date:  2012-04-30       Impact factor: 3.295

9.  Role of Chlamydia trachomatis in miscarriage.

Authors:  David Baud; Genevieve Goy; Katia Jaton; Maria-Chiara Osterheld; Serafin Blumer; Nicole Borel; Yvan Vial; Patrick Hohlfeld; Andreas Pospischil; Gilbert Greub
Journal:  Emerg Infect Dis       Date:  2011-09       Impact factor: 6.883

10.  Predicting phenotype and emerging strains among Chlamydia trachomatis infections.

Authors:  Deborah Dean; William J Bruno; Raymond Wan; João P Gomes; Stéphanie Devignot; Tigist Mehari; Henry J C de Vries; Servaas A Morré; Garry Myers; Timothy D Read; Brian G Spratt
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.